sitagliptin
Showing 1 - 25 of 237
Type 2 Diabetes Trial in Beijing (Sitagliptin, Sitagliptin combined with Beidougen capsule)
Recruiting
- Type 2 Diabetes
- Sitagliptin
- Sitagliptin combined with Beidougen capsule
-
Beijing, Beijing, ChinaBeijing Chao-yang Hospital, Capital Medical University
Dec 29, 2022
Perioperative Sitagliptin Medication for Reduction of
Recruiting
- Systemic Inflammatory Response Syndrome
- Sitagliptin
-
Münster, North Rhine-Westphalia, GermanyUniversity Hospital Münster
Feb 10, 2023
Compensated Cirrhosis, Decompensated Cirrhosis Trial in New Delhi (Metformin, Sitagliptin, Dapagliflozin)
Not yet recruiting
- Compensated Cirrhosis
- Decompensated Cirrhosis
- Metformin
- +2 more
-
New Delhi, Delhi, IndiaDr Rakesh Kumar Jagdish
Nov 23, 2023
Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis
Not yet recruiting
- Bone Marrow Transplant Complications
- +4 more
- Sitagliptin
- +2 more
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023
Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,
Completed
- Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
- Dapagliflozin/sitagliptin FDC
- +2 more
-
Berlin, GermanyResearch Site
Jun 30, 2022
Diabetes, Type 2 Diabetes Trial (Sitagliptin, Metformin, Placebo to sitagliptin)
Completed
- Diabetes Mellitus
- Type 2 Diabetes
- Sitagliptin
- +5 more
- (no location specified)
Sep 9, 2022
Diabetes Type I Trial in Williamsville (sitagliptin, Placebo)
Withdrawn
- Diabetes Type I
- sitagliptin
- Placebo
-
Williamsville, New York115 Flint Road
Mar 8, 2022
Type 1 Diabetes Trial in Milan (Sitagliptin, Professional CGM)
Not yet recruiting
- Type 1 Diabetes
- Sitagliptin
- Professional CGM
-
Milan, ItalyASST FBF Sacco
Jun 14, 2022
NAFLD Trial (sitagliptin and metformin, Sitagliptin, Metformin)
Completed
- NAFLD
- sitagliptin and metformin
- +2 more
- (no location specified)
Jul 28, 2022
Diabetes, Type 2, Severe Insulin Deficient Diabetes Trial in Beijing (Glimepiride, Sitagliptin)
Recruiting
- Diabetes Mellitus, Type 2
- Severe Insulin Deficient Diabetes
- Glimepiride
- Sitagliptin
-
Beijing, Please Select, ChinaPeking University People's Hospital
May 18, 2022
Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia Trial in Beijing (Sitagliptin, Danazol)
Recruiting
- Immune Thrombocytopenia
- +3 more
- Sitagliptin
- Danazol
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 25, 2022
Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)
Completed
- Pre-diabetes
- Type 2 Diabetes
- Exenatide
- +2 more
-
Philadelphia, Pennsylvania
- +2 more
May 16, 2022
Type 2 Diabetes Trial (Sitagliptin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Sitagliptin
- Placebo
- (no location specified)
Oct 27, 2021
Type 2 Diabetes Trial in Seongnam (Sitagliptin, Dapagliflozin, Lobeglitazone)
Completed
- Type 2 Diabetes
- Sitagliptin
- +4 more
-
Seongnam, Gyeonggi, Korea, Republic ofSoo Lim
Jan 2, 2022
Covid19, Diabetes, Type 2, CKD Trial in Milan (Sitagliptin)
Not yet recruiting
- Covid19
- +2 more
- Sitagliptin
-
Milan, ItalyASST FBF Sacco
Sep 27, 2021
Type2 Diabetes Trial in Evansville (Bexagliflozin, Metformin, Glimepiride)
Completed
- Type2 Diabetes Mellitus
- Bexagliflozin
- +3 more
-
Evansville, IndianaClinical Research Site
Jul 1, 2021
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022
Polycystic Ovary Syndrome, Infertility, ART Trial in Tehran (, metformin, Sitagliptin)
Recruiting
- Polycystic Ovary Syndrome
- +2 more
- placebo
- +3 more
-
Tehran, Iran, Islamic Republic ofMahdiyeh educational hospital
Mar 19, 2021
Type 2 Diabetes, PreDiabetes Trial in Johor Bahru (Sitagliptin)
Completed
- Type 2 Diabetes Mellitus
- PreDiabetes
- Sitagliptin
-
Johor Bahru, Johor, MalaysiaHospital Sultan Ismail
Mar 13, 2022
Type 2 Diabetes Trial in Seongnam (Ipragliflozin, Sitagliptin)
Recruiting
- Type 2 Diabetes Mellitus
- Ipragliflozin
- Sitagliptin
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Mar 29, 2021
Cystic Fibrosis, Pancreatic Insufficiency Trial in Philadelphia (Sitagliptin, Placebo)
Completed
- Cystic Fibrosis
- Pancreatic Insufficiency
- Sitagliptin
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia and University of Pennsylvan
Feb 24, 2022
Replication of GRADE Diabetes Trial in Healthcare Claims Data
Completed
- Diabetes
- Sitagliptin
- Glimepiride
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 18, 2021
Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)
Completed
- Type 2 Diabetes Mellitus
- Hypertension
- Placebo
- +3 more
-
Nashville, TennesseeVanderbilt University
Feb 8, 2022
Type 1 Diabetes, Monogenic Diabetes Trial in Boston (Metformin Extended Release Oral Tablet, Sitagliptin)
Enrolling by invitation
- Type 1 Diabetes
- Monogenic Diabetes
- Metformin Extended Release Oral Tablet
- Sitagliptin
-
Boston, MassachusettsJoslin Diabetes Center
Jan 4, 2022